KARI PROVOST: Open Payments
NPI 1376892521 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,049 in 58 payments from 12 companies in 2025. Trend: 2023 $796 · 2024 $1,350 · 2025 $2,049
Food & beverage: $2,049
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 11 | $691 |
| Phathom Pharmaceuticals, Inc. | 8 | $317 |
| Ardelyx, Inc. | 10 | $280 |
| Gilead Sciences, Inc. | 8 | $273 |
| Regeneron Healthcare Solutions, Inc. | 4 | $156 |
| GENZYME CORPORATION | 4 | $83 |
| ABBVIE INC. | 4 | $81 |
| Janssen Biotech, Inc. | 3 | $54 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
| Novo Nordisk Inc | 2 | $33 |
Products named: REZDIFFRA, VOQUEZNA, IBSRELA, DUPIXENT, TREMFYA, MAVYRET, RINVOQ, IQIRVO.
Industry payments across CA — which companies pay providers there.
